(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Redemption at Maturity and Delisting of "DaShenLin Convertible Bonds"

Summary by 6ix AI

DaShenLin Pharmaceutical Group Co., Ltd. has announced the redemption at maturity and delisting of its convertible bonds, known as "DaShenLin Convertible Bonds". The bonds will stop trading shortly before their maturity date, with specific dates outlined for trading cessation and redemption. Investors will receive a specified amount per bond, with details on the payment process and tax implications provided. The bonds will officially be delisted following the redemption process, which is set to occur shortly after the maturity date.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries